Low-grade epithelial ovarian cancer: what a radiologist should know

被引：25

作者：

Elsherif, Sherif ^{[1
]}

Javadi, Sanaz ^{[1
]}

Viswanathan, Chitra ^{[1
]}

Faria, Silvana ^{[1
]}

Bhosale, Priya ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, Houston, TX 77030 USA

来源：

BRITISH JOURNAL OF RADIOLOGY | 2019年 / 92卷 / 1095期

关键词：

SEROUS OVARIAN; PERITONEAL CANCER; F-18-FDG PET/CT; ULTRASOUND FEATURES; STAGING SYSTEM; FALLOPIAN-TUBE; CELL TUMORS; CARCINOMA; CT; THERAPY;

D O I：

10.1259/bjr.20180571

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Ovarian cancer accounts for the death of over 100,000 females every year and is the most lethal gynecological malignancy. Low-grade serous ovarian carcinoma (LGSOC) and high-grade serous ovarian carcinoma (HGSOC) have been found to represent two distinct entities based on their molecular differences, clinical course, and response to chemotherapy. Currently, all ovarian cancers are staged according to the revised staging system of the International Federation of Gynecology and Obstetrics (FIGO). Imaging plays an integral role in the diagnosis, staging, and follow-up of ovarian cancers. This review will be based on the two-tier grading system of epithelial ovarian cancers, with the main emphasis on serous ovarian cancer, and the role of imaging to characterize low-grade vs high-grade tumors and monitor disease recurrence during follow-up.

引用

页数：12

共 65 条

[11] The cytogenetic theory of the pathogenesis of human adult male germ cell tumors - Review article [J].

Chaganti, RSK ;

Houldsworth, J .

APMIS, 1998, 106 (01) :80-83

[12] Pathology and classification of ovarian tumors [J].

Chen, VW ;

Ruiz, B ;

Killeen, JL ;

Coté, TR ;

Wu, XC ;

Correa, CN .

CANCER, 2003, 97 (10) :2631-+

[13] Chromosome 12p abnormalities in dysgerminoma of the ovary: a FISH analysis [J].

Cossu-Rocca, P ;

Zhang, SB ;

Roth, LM ;

Eble, JN ;

Zheng, WX ;

Karim, FWA ;

Michael, H ;

Emerson, RE ;

Jones, TD ;

Hattab, EM ;

Cheng, L .

MODERN PATHOLOGY, 2006, 19 (04) :611-615

[14] Low Grade Serous Ovarian Carcinoma: From the molecular characterization to the best therapeutic strategy [J].

Della Pepa, Chiara ;

Tonini, Giuseppe ;

Santini, Daniele ;

Losito, Simona ;

Pisano, Carmela ;

Di Napoli, Marilena ;

Cecere, Sabrina Chiara ;

Gargiulo, Piera ;

Pignata, Sandro .

CANCER TREATMENT REVIEWS, 2015, 41 (02) :136-143

[15]

DEMBO AJ, 1990, OBSTET GYNECOL, V75, P263

[16] Expression of hypothalamic-pituitary-gonadal axis-related hormone receptors in low-grade serous ovarian cancer (LGSC) [J].

Feng, Zheng ;

Wen, Hao ;

Ju, Xingzhu ;

Bi, Rui ;

Chen, Xiaojun ;

Yang, Wentao ;

Wu, Xiaohua .

JOURNAL OF OVARIAN RESEARCH, 2017, 10

[17] Increase in post-therapy tumor calcification on CT scan is not an indicator of response to therapy in low-grade serous ovarian cancer [J].

Ganeshan, Dhakshinamoorthy ;

Bhosale, Priya ;

Wei, Wei ;

Ramalingam, Preetha ;

Mudasiru-Dawodu, Eniola ;

Gershenson, David ;

Sun, Charlotte ;

Iyer, Revathy .

ABDOMINAL RADIOLOGY, 2016, 41 (08) :1589-1595

[18] Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum [J].

Gershenson, David M. ;

Sun, Charlotte C. ;

Iyer, Revathy B. ;

Malpica, Anais L. ;

Kavanagh, John J. ;

Bodurka, Diane C. ;

Schmeler, Kathleen ;

Deavers, Michael .

GYNECOLOGIC ONCOLOGY, 2012, 125 (03) :661-666

[19] Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase [J].

Grabowski, Jacek P. ;

Harter, Philipp ;

Heitz, Florian ;

Pujade-Lauraine, Eric ;

Reuss, Alexander ;

Kristensen, Gunnar ;

Ray-Coquard, Isabelle ;

Heitz, Julia ;

Traut, Alexander ;

Pfisterer, Jacobus ;

du Bois, Andreas .

GYNECOLOGIC ONCOLOGY, 2016, 140 (03) :457-462

[20] Bevacizumab Shows Activity in Patients With Low-Grade Serous Ovarian and Primary Peritoneal Cancer [J].

Grisham, Rachel N. ;

Iyer, Gopa ;

Sala, Evis ;

Zhou, Qin ;

Iasonos, Alexia ;

DeLair, Deborah ;

Hyman, David M. ;

Aghajanian, Carol .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (06) :1010-1014

← 1 2 3 4 5 6 7 →